How Do I Treat Low Gradient & Severe Aortic Stenosis?

Vinod Thourani

MR Quantification: Guideline Gaps

Piedmont's Marcus Heart Valve Center

Left Sided AngioVAC, ECMO, ViV TMVR, ViV TAVR

University of Miami

J. Barrientos

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

The UPSTREAM Management of Aortic Stenosis in the Future

ARCH Advanced Revascularization Symposium

M. Leon

ACC 2023: Mitral Regurgitation - Five Diagnostic and Therapeutic Cha…

ACC 2023 Conference Coverage

G. W. Stone

Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thraco…

Miami Valves

A. Kiser

Percutaneous Mitral Paravalvular Leak Closure

Congenital and Structural Interventions

H. Sievert

Valve Replacement for Pure Native Aortic Regurgitation from Alpha to…

Patrick Serruys

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

American College of Cardiology

D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy

Secondary Mitral Regurgitation: Clinical Assessment, Quantitave Meas…

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

P. Grayburn

CAD and Aortic Stenosis: Just Treat the Valve (Most of the Time)

ARCH Advanced Revascularization Symposium

M. Chung

A Story of a Left-Sided Bioprosthetic Valve Thrombosis

University of Miami

Z. Gunga

Improving Outcomes in Women with Valvular Heart Disease

Cedars Sinai

J. Chikwe

TCT 2022: Transcatheter Edge-to-Edge Repair in Patients With Severe …

TCT 2022 Conference Coverage

M. Alkhouli

Evolution in the Treatment of Valvular Heart Disease: From Surgery t…

Gilbert Tang

My Most Valve-in-Valve: TAVR in TAVR

University of Miami

L. Cressa

The Future of TAVR - Where Will We Be In 2030? My Crystal Ball

University of Miami

E. Grube

Valvular Heart Disease and Aortic Stenosis Management in 2020: What …

New York Transcatheter Valves 2019

R. Nishimura